Tectonic Therapeutic TECX
NASDAQ TECX
$22.54 -0.13 (-0.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Gains from Sales and Divestitures (2022 - 2026)

Updated

Tectonic Therapeutic's Gains from Sales and Divestitures came in at -$23,000 for Q1 2026.

Analysis

Tectonic Therapeutic (TECX) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends

For FY2025, Tectonic Therapeutic's Gains from Sales and Divestitures was -$153,000.

  • Going back by year, Gains from Sales and Divestitures was -$9,000 in FY2023 and -$59,000 in FY2022.
  • The Q1 2026 figure represents the highest quarterly Gains from Sales and Divestitures since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tectonic Therapeutic 433.56 Mn 433.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -23,000.00
Sep 30, 2025 -93,000.00
Jun 30, 2025 -60,000.00
Dec 31, 2023 -9,000.00
Dec 31, 2022 -118,000.00
Sep 30, 2022 50,000.00
Jun 30, 2022 18,000.00
Mar 31, 2022 -9,000.00
API Access

Tectonic Therapeutic Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TECX&period=max&api_key=YOUR_API_KEY